Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1770121 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.17Day −3.65%Mkt cap $882M1Y −28.8%Off 52W high −51.6%Vol (1Y) 91.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest14.3% of sh out |
| Days to cover13.2d |
| 13F net flow (QoQ)+1.91% |
| Top-10 13F concentration74.9% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$242.0M |
| ROE−118.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−22.1% |
| 1Y−28.8% |
| 3Y−45.9% |
| 5Y−81.5% |
| Since incept. (ann.)−36.7% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)91.7% |
| Ann. volatility (3Y)134.3% |
| Sharpe (1Y)−0.02 |
| Sharpe (3Y)0.35 |
| Max drawdown (1Y)−54.7% |
| Max drawdown (3Y)−88.1% |
| Beta (3Y vs SPY)3.81 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 37.4M | $108M | 13.45% | +0.0% |
| Flagship Pioneering, LLC | 25.0M | $72M | 8.98% | +0.0% |
| BlackRock, Inc. | 14.2M | $41M | 5.12% | +0.1% |
| STATE STREET CORP | 10.5M | $30M | 3.79% | +30.8% |
| CANADA PENSION PLAN INVESTMENT BOARD | 10.2M | $29M | 3.67% | −0.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.4M | $21M | 2.67% | new |
| BAILLIE GIFFORD & CO | 6.6M | $19M | 2.37% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 4.2M | $12M | 1.50% | +1.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.17 | — | — | — |
| 2025-09-30 | 2025-11-06 | −$0.16 | — | — | — |
| 2025-06-30 | 2025-08-11 | −$0.39 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$0.21 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
